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The AIRE protein plays a remarkable role as a regulator of
central tolerance by controlling the promiscuous expression of
tissue-specific antigens in thymic medullary epithelial cells.
Defects in the AIRE gene cause the autoimmune polyendocri-
nopathy-candidiasis-ectodermal dystrophy, a rare disease fre-
quent in Iranian Jews, Finns, and Sardinian population. To this
day, the precise function of the AIRE protein in regulating tran-
scription and its interacting proteins has yet to be entirely clar-
ified. The knowledge of novel AIRE interactors and their precise
role will improve our knowledge of its biological activity and
address some of the foremost autoimmunity-related questions.
In this study, we have used a yeast two-hybrid system to identify
AIRE-interacting proteins. This approach led us to the discov-
ery of a newAIRE-interacting protein calledDAXX.Theprotein
is known to be a multifunctional adaptor with functions both in
apoptosis and in transcription regulation pathways. The inter-
action between AIRE and DAXX has been validated by in vivo
coimmunoprecipitation analysis and colocalization study in
mammalian cells. The interaction has been further confirmed
by showing in transactivation assays that DAXX exerts a strong
repressive role on the transcriptional activity of AIRE.
Autoimmune polyendocrinopathy-candidiasis-ectodermal
dystrophy (MIM 240300) is a rare recessive disease character-
ized by a variable combination of autoimmune endocrine tis-
sues and liver destruction, mucocutaneous candidiasis, and
ectodermal dystrophies (1–3). The defective gene, called AIRE
(autoimmune regulator; MIM 607358), is a transcriptional reg-
ulator that coordinates the expression of a set of tissue-specific
antigens inmedullary thymic epithelial cells where self-reactive
T cells experience negative selection. The absence of thymic
AIRE expression leads to the escape of autoreactive T cells and
results in manifest autoimmunity (4–7). Therefore, AIRE is a
key molecule in the establishment of immunological tolerance.
AIRE protein consists of multiple structural domains, con-
served in the mouse homologue, which are indicative of a role
as transcriptional regulator (8). AIRE is detected in the nucleus,
where it is localized in the nuclear bodies associated with the
nuclear matrix fraction of the cells (9, 10). Indeed, AIRE con-
tains a potential bipartite nuclear localization signal, consisting
of amino acids 110–114 and 131–133, even though only the
latter part constitutes a functional nuclear localization signal
(11). AIRE shares several domains with members of the Sp100
family of proteins, such as HSR, SAND, and PHD.3 The Sp100
family of proteins is a group of transcriptional regulators
involved in both transcriptional activation and repression. The
AIREN-terminal HSR domain is an integral domain that drives
homodimerization, subcellular localization, and protein-pro-
tein interactions (9, 12). Recently, theHSRdomain function has
been better defined by alignment andhomologymodeling stud-
ies, and for this reason the motif has been renamed the CARD
domain (13). The CARD domain is a functional structure
required for the correct function of signaling machineries that
trigger apoptosis, inflammation, and innate immune recogni-
tion. The SANDdomain is characteristic of proteins involved in
chromatin-dependent transcriptional regulation and contains
a conserved KDWD motif essential for DNA recognition (14).
In addition to the DNA binding property, the SAND domain
cooperates with the HSR/CARD domain in the homodimeriza-
tion and nuclear localization function of AIRE (9, 12). AIRE
contains two PHD zinc finger-type motifs that are known to be
chromatin remodeling factors, indicating again thatAIREoper-
ates as a transcriptional regulator (15). AIRE PHDs are multi-
functional domains, with transactivation and repression activ-
ity (16–18). In addition, it is debated whether the AIRE PHD
behaves as an E3 ubiquitin ligase (19, 20). Interestingly, it has
been recently shown by nuclear magnetic resonance solution
structure that AIRE PHD1 binds unmethylated histone
H3K4me0, an usual target of repressor factors involved in keep-
ing chromatin in the inactive state (21–23). However, AIRE
binding to H3-K4me0 is associated with methylation of Lys-4
leading to activation instead of repression of the adjacent chro-
matin (24). Finally, the AIRE protein includes four LXXLL
motifs that mediate the binding of several coactivators to the
nuclear receptors. The last LXXLLmotif and the flanking PXX-
PXP sequence are essential for the transactivation capacity of
AIRE (18). This finding is supported by the presence in this
region of an autoimmune polyendocrinopathy-candidiasis-ec-
todermal dystrophy causing mutation (25). Previous studies
have shown that AIRE is present in soluble high molecular
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weight complexes, and this evidence suggests the existence of
several interacting proteins (9). A very recent work has just
identified, via AIRE-targeted coimmunoprecipitation, a
wide set of interactors that belong to many classes such as
nuclear transport, chromatin binding/structure, transcrip-
tion, and pre-mRNA processing (26). However, to this day,
just a fewAIRE protein partners have been functionally char-
acterized, and those needed to be mentioned are as follows:
1) a heterotrimeric complex of DNA-dependent protein
kinase, consisting of Ku70, Ku80, and the DNA protein
kinase catalytic subunit responsible for the phosphorylation
of the AIRE protein at Thr-68 and Ser-156 that modulate
AIRE transactivation ability (27); 2) PIAS1 (protein inhibitor
of activated STAT) protein that functionally interacts with
AIRE to regulate the activity of AIRE target genes (28); 3) p63
protein, which interacts with the SAND domain of AIRE to
regulate human leukocyte antigen class II genes (29); and 4)
CREB-binding protein (CBP), a general transcriptional
coregulator with histone acetyltransferase properties. CBP
has been reported to bind AIRE directly in vitro. CBP colo-
calizes with AIRE into the nuclear bodies in monocytic cell
cultures, and when coexpressed with AIRE, it enhances the
transcription of reporter genes (17, 31). Despite the great
amount of work on the AIRE protein, its precise mechanism
of action still remains unsolved. Therefore, to clarify the
functional role of AIRE and identify potential partners, we
performed a yeast two-hybrid screen and isolated DAXX, a
protein involved in apoptosis and in transcription regula-
tion. The interaction between AIRE and DAXX was con-
firmed in vivo by coimmunoprecipitation and colocalization
studies. Furthermore, by transactivation analysis, we estab-
lished that DAXX protein acts as a repressor of AIRE.
MATERIALS ANDMETHODS
Plasmids
Plasmids Used in Yeast Two-hybrid Assay—TheAIRE cDNA
(aa 1–517) and deletion fragments of AIRE (1–413, 1–161,
1–100, 12–517, and 68–517) were amplified by PCR using
primers that carry NcoI and EcoRI restriction sites. The frag-
ments were then cloned into pGBKT7-DNA-BD vector
(Clontech). The full-length cDNA of DAXX protein was
cloned into the pGAD expression vector (Clontech) using
EcoRI and NotI restriction sites. pGAD-DAXX cod629stop
and pGBKT7-AIRE1–517-W78R were obtained by site-spe-
cific mutagenesis.
Plasmids Used in Luciferase Assay—Full-length AIRE was
cloned into EcoRI and NotI cloning sites of pEF5HA plasmid
that was kindly provided by Nunzio Bottini (La Jolla Institute
for Allergy and Immunology, La Jolla, CA). pEFHA vector
allows the expression of constructs in fusion with an N-termi-
nal HA tag and under control of the EF promoter. The human
full-length DAXX cDNA cloned into pCMV-XL5 plasmid was
purchased from OriGene (Rockville, MD). The insulin pro-
moter (pMG3-insulin/Luc) reporter plasmid (kindly provided
by Paolo Moi, University of Cagliari, Italy) carries a single copy
of the insulin promoter region that is cloned upstream of the
luciferase reporter gene. Control pGL4 plasmid, driving consti-
tutive expression of Renilla luciferase, was purchased from
Promega.
Plasmids Used in Colocalization Assay—The full-length
AIRE cDNA was amplified and cloned in Monster green fluo-
rescent protein expression vector (Promega) carrying EcoRV
restriction site. pCMV-XL5-DAXX was purchased from Ori-
Gene (Rockville, MD).
Plasmids Used in Coimmunoprecipitation Assay—The full-
length AIRE cDNA was amplified and cloned into pEF5HA
using primers that carry EcoRI-NotI restriction sites and into
the EcoRI site of pcDNA3.1 V5/C (Invitrogen).
The AIRE constructs lacking 28, 132, 384, and 445 C-termi-
nal amino acids were obtained by site-specificmutagenesis per-
formed on pEF5HAAIRE full-length construct. The constructs
lacking 11 and 67 N-terminal amino acids were obtained by
PCR and cloned in pEF5HA vector. pCDNA 3.1 Xpress DAXX
was prepared by PCR amplification with primers carrying
EcoRI-Xba-I sites, and pCMV-XL5-DAXX was purchased
from OriGene (Rockville, MD).
Plasmids Used in GST-Pulldown Assay—The pGEX-2T-
AIRE aa 1–161 was created by site-specific mutagenesis that
inserted a stop codon at position 162 in the pGEX-2T-AIRE
full-length construct.
Antibodies
Polyclonal antibody against DAXX was purchased from Cell
Signaling Technology (Boston, MA); anti-V5 monoclonal anti-
body was from Invitrogen; anti-HA monoclonal antibody
(clone 16B12) was from Covance (Berkeley, CA); polyclonal
anti-HDAC1 and HDAC2 were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Anti-rabbit Ig Texas Red sec-
ondary antibody, anti-mouse, and anti-rabbit secondary anti-
body were from GE Healthcare. Anti-actin antibody was pur-
chased from Sigma.
Two-hybrid Assay Screens
Yeast two-hybrid assays were performed using GAL4
Matchmaker Two-hybrid System 3 (Clontech). A human
thymus Matchmaker cDNA library in the pACT2 prey plas-
mid (Clontech) was screened for proteins that interact with
AIRE (aa 1–517) in the pGBKT7-DNA-BD bait plasmid
using the AH109 yeast reporter strain. In this study we used
an AIRE construct lacking 28 C-terminal amino acids (AIRE
aa 1–517) to eliminate the autoactivation phenomenon of
the full-length AIRE. The yeast cells were transformed by the
lithium acetate method and were plated on synthetic drop-
out (SD) medium lacking leucine and tryptophan (low strin-
gency). The growing colonies were selected on synthetic
dropout (SD) medium lacking leucine tryptophan, histidine,
and adenine (high stringency) allowing the production of
-galactosidase. Positive clones were selected, and plasmid
DNA was isolated and fully sequenced. Seven clones were
found to encode the DAXX protein and precisely its C-ter-
minal region (aa 629–740).
To map the AIRE interaction domain, PCR fragments
encoding deletion derivatives of AIRE were amplified and
subcloned into pGBKT7 DNA-BD; the mutant form of
pGBKT7-AIRE (pGBKT7-AIRE-(1–517)-W78R) was ob-
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tained by site-specific mutagenesis. All constructs were
cotransformed with a full-length pGAD-AD-DAXX in
AH109 yeast strain. To establish whether the Ser/Pro/Thr-
rich region of DAXX protein is the only domain involved in
AIRE interaction, we produced a pGAD-DAXX construct
where a stop codon at position 629 was created by site-spe-
cific mutagenesis. This construct lacking 111 amino acids
was cotransformed with pGBKT7AIRE (aa 1–517) and
pGBKT7-AIRE (aa 1–161) in AH109 yeast strains.
-Galactosidase Activity Assay
The quantitative -galactosidase activity assay was per-
formed using p-nitrophenyl -D-galactopyranoside as sub-
strate according to the Clontech manual with some minor
modifications. Noninteracting proteins grown on synthetic
dropout (SD)medium lacking leucine and tryptophan aswell as
interacting proteins grown on synthetic dropout (SD) medium
lacking leucine, tryptophan, histidine, and adenine were inoc-
ulated in the respective culture medium from a single fresh
yeast colony and incubated overnight at 30 °C. The supernatant
was harvested by centrifugation at 13,000 g for 2min, and 400
l of the supernatant was mixed with 600 l of fresh prepared
Assay Buffer (2:1 ratio of 0.5 M sodium acetate, pH 4.5, to 100
mM p-nitrophenyl -D-galactopyranoside (Sigma)) and incu-
bated at 30 °C for 4 h. The reaction was stopped with the addi-
tion of 200 l of 1 M Na2CO3. The A410 nm of each reaction was
recorded by a spectrophotometer. Yeast transformations were
performed in duplicate, and each yeast colony was assayed in
triplicate.
Cell Culture and Transient Transfections
HeLa and COS-1 cells were grown in Dulbecco’s modified
Eagle’s medium (high glucose) supplemented with 10% fetal
calf serum, 100 units/ml penicillin, 100 g/ml streptomycin,
and 2 mM glutamine (Invitrogen) at 37 °C and 5% CO2. All
transfections were performed by Lipofectamine 2000 method
according to themanufacturer’s instructions (Invitrogen). Each
experiment was performed at least three times, andwithin each
experiment, transfections were performed in quadruplicate.
Proteasome Inhibition Assay
COS-1 cells (3 105) were transiently transfected with 1.5
g of pEF5HA-AIRE aa 1–100. 24 h from transfection, cells
were treated with 2 and 5 M proteosome inhibitor benzyloxy-
carbonyl-Leu-Leu-Leu-H (MG132; Sigma) for 3 h or left
untreated. Cells were than harvested and lysed in sample buffer,
and the lysates were analyzed by anti-HAWestern blotting.
Luciferase Assay
300 ng of pMG3-insulin/Luc reporter plasmid and 50 ng of
control pGL4 plasmid were cotransfected in HeLa and COS-1
cells with the appropriate amount of HA-tagged full-length
AIRE (2 g) and variable amounts of DAXX construct ranging
from100 to 500 ng using the Lipofectamine 2000method. After
incubation for 24 h, cells were washed with 1 PBS and lysed.
Luciferase assayswere performed on cell lysates using theDual-
Luciferase reporter assay kit from Promega (Madison, WI)
according to the manufacturer’s instructions, and reading
luminescence onMicroLumat LB 96P luminometer (Berthold).
The ratio between firefly and Renilla luciferase activity was
then plotted against the expression of constructs assessed by
densitometric scanning of anti-HA and anti-DAXX blots of
total lysates. For deacetylation inhibition studies, trichostatinA
(TSA) (Sigma) was added 5 h following transfections at a final
concentration of 100 ng/ml and incubated for 24 h.
Immunofluorescence
1.5  105 HeLa cells seeded on culture slides were trans-
fected with 320 ng of GFP-AIRE and 320 ng of pXL5-DAXX.
After 48 h of transfection, HeLa cells were fixed with methanol
for 5 min on ice and with ethanol at room temperature, perme-
abilized with PBS containing 1% Triton X-100 for 10 min at
room temperature, and blocked for 45 min with 8% bovine
serum albumin in PBS. Anti-DAXX staining was performed
by incubation for 1 h at 37 °C with anti-DAXX polyclonal
antibody (Cell Signaling Technology) diluted 1:200 in PBS
containing 3% bovine serum albumin. The antigen-primary
antibody complex was detected by incubating for 20 min at
37 °C with anti-rabbit Ig Texas Red secondary antibody (GE
Healthcare) diluted 1:50 in 3% bovine serum albumin in PBS.
The nucleus were stained with 4,6-diamidino-2-phenylin-
dole diluted 1:1000 in PBS for 5 min at room temperature.
The culture slides were mounted with a coverglass in
Vectashield mounting medium (Vector Laboratories).
Microscopic observation was performed under a confocal
laser-scanning microscope LSM Leica equipped with fluo-
rescein isothiocyanate and TRITC filter sets.
Coimmunoprecipitation and Homodimerization Inhibition
Assay
COS-1 cells (106) transfected with HA-AIRE constructs
described above and pXL5-DAXXwere lysed on ice in 0.5ml of
lysis buffer containing 50 mM Tris-HCl, pH 7.5, 50 mM NaCl,
0.2%Nonidet P-40, 5MZnCl2, 30mMNa4P2O7, 50mMNaF, 2
mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluo-
ride, and protease inhibitors tablet (Roche Applied Science).
Cell lysates were centrifuged at 12,000  g for 20 min at 4 °C,
and supernatants (500–700 g of protein extracts for each
experiment) were preclarified with 50 l of 50% protein
G-Sepharose 4B resin (GE Healthcare) for 4 h at 4 °C. After
centrifugation, 3 l of anti-HA antibody (Covance) were
added to the supernatant followed by overnight agitation at
4 °C. To recover protein complexes, 50 l of 50% protein
G-Sepharose 4B resin were added into each sample and incu-
bated by agitation for additional 4 h at 4 °C. Resin was
washed four times with PBS containing 0.2% Nonidet P-40,
and the immune complexes were released from the resin by
boiling in 30 l of 2 sample buffer. Samples were analyzed
by 10% SDS-PAGE and Western blotting using polyclonal
antibody against DAXX (diluted 1:3000) using ECL Plus
chemiluminescence method (GE Healthcare). In the
homodimerization inhibition assay, COS-1 cells were trans-
fected with a constant amount of HA-AIRE and V5-AIRE as
well as increasing amounts of Xpress-DAXX (0.6, 1.2, and
2.0 g). IPs were performed from total lysates of transfected
cells using 1 g of anti-V5 antibody.
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GST-Pulldown
Expression of GST fusion proteins were performed follow-
ing the manufacturer’s instructions (GE Healthcare). n brief,
Escherichia coli strain BL21SI was transformed with pGEX-
2T-GST and pGEX-2T-AIRE (aa 1–160) in 2 YTA broth
containing 100 g/ml ampicillin and induced for protein
expression with 0.1mM isopropyl 1-thio--D-galactopyrano-
side at 30 °C for 3 h. Bacterial cells were harvested and lysed.
Appropriate volumes of MagneGST-glutathione beads (Pro-
mega) were added to the supernatants and incubated for 30
min at 4 °C. After washing, the purified proteins were eluted
from beads by incubation with 200 l of Elution Buffer con-
taining the following: 100 mM glutathione, 50 mM Tris-HCl,
pH 8.1, 1% Triton X-100, 100 mM NaCl. Then 2 or 5 g of
each purified GST fusion protein were bound with 5 or 10 l
of MagneGST-glutathione beads (Promega) for 1 h in 1
PBS at 4 °C. The proteins-beads complexes were blocked for
1 h with 5% bovine serum albumin in 1 PBS and then incu-
bated with 10 l of radiolabeled DAXX protein produced
with the TNT system (Promega) for 2 h at 4 °C in Binding
Buffer containing the following: 10 mM Hepes, pH 8, 0.5 M
NaCl, 1 mM MgCl2, 12,5% glycerol, 0.5 mM dithiothreitol.
After extensive washes with 1% Nonidet P-40 in 1 PBS, the
GST fusion protein-DAXX complex was removed from the
beads by competition using 20 l of Elution Buffer. 10 l of
eluted solution were added with 4 l of 2 Sample Buffer
and analyzed in 12% SDS gel. The gel was than exposed to
autoradiography after being fixed and dried.
RESULTS
HSR/CARD Domain of AIRE Interacts with Ser/Pro/Thr-rich
Domain of DAXX—Here, we sought to assess potential AIRE-
interacting proteins through the yeast two-hybrid assay. In
detail, a GAL4-DNA-BDAIRE fusion protein (pGBKT7-AIRE-
(1–517)) was used as a bait to screen aGAL4-AD-tagged cDNA
expression library of human thymus where AIRE is highly
expressed.We identified seven positive clones that encoded the
C-terminal region of DAXX protein (aa 629–740) correspond-
ing to a Ser/Pro/Thr-rich domain. The interaction was then
confirmed by retransformation (Fig. 1).
DAXX is a ubiquitously expressed protein with a particu-
larly high expression in the thymus and testes (32). It colo-
calizes predominantly in PML-nuclear bodies where
together with PML the protein influences apoptosis and
transcription (33, 34). However, several DAXX-interacting
proteins are not located solely in the PML- nuclear bodies
indicating that DAXX is also localized in alternative nuclear
structures. DAXX was initially identified as a binding pro-
tein of Fas death domain and was shown to potentiate Fas-
mediated apoptosis (32). Paradoxically, Daxx/ mice
showed embryonic lethality related to widespread apoptosis.
These data taken together indicate that DAXX has antiapo-
FIGURE 1. AIRE interacts with DAXX in yeast two-hybrid assay. Left panel, schematic representation of AIRE and DAXX constructs. A and I, full-length AIRE
andDAXX. B,AIRE construct used to screenhuman thymus library.C–H,AIRE constructs used tomap interaction domains. L,DAXX fragment that interactswith
AIRE in yeast two-hybrid assay.M,DAXX construct used tomap interaction domain. Right panel, quantitative two hybrid assay.-Galactosidase units detected
by the quantitative assay are shown as gray bars. The constructs used in each assay correspond to the aligned left panel. Plus andminus symbols indicate the
transformant capabilities togrowonhigh stringencymediumthroughADEandHIS reportergeneactivation.CC, coiled coil;NLS, nuclear localization signal;PST,
Pro/Ser/Thr.
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ptotic function and is essential for embryonic development
(35). Biochemically, DAXX may act as a transcriptional reg-
ulator that can mainly repress transcription (36–39). Thus,
DAXXmight regulate cellular processes by modulating tran-
scription of specific genes under different conditions and has
been found to take part of a large multiprotein complex that
includes core histones and histone deacetylase complexes
(HDACs) (40), as well as a chromatin remodeling complex
that includes the ATRX protein (41, 42). DAXX can also
associate with sumoylated CBP and represses CBP transcrip-
tional activity through HDAC2 recruitment (43). On the
other hand, DAXX-mediated transcriptional repression can
be mitigated by sumoylated PML that attracts DAXX to the
nuclear domain (PODs) (44). However, the mechanism by
which DAXX binds to sumoylated PML and sumoylated
transcription factors is still largely unclear. As DAXX asso-
ciates directly with a number of DNA binding transcription
factors, including Pax3 and Pax5 (36, 37), ETS1 (38), p53
(39), and its family members p73 and p63 (45), glucocorti-
coid receptor (46), androgen receptor (47), and Smad4 (48),
it is likely that it represents a crucial link between DNA
binding factors and transcriptional regulatory complexes.
DAXX-mediated transcriptional repression is due to inter-
action with HDAC (40), and indeed the SPT domain of
DAXX recruits histone deacetylases leading to inactive chro-
matin structure and transcriptional repression.
We carried out deletion studies to map the AIRE domains
involved in the interaction with DAXX. PCR fragments
encoding deletion derivatives of AIRE were subcloned into
pGBKT7-GAL4 DNA-BD and cotransformed in yeast cells
with full-length pGAD GAL4-AD-DAXX. We used six trun-
cated constructs lacking both the C- and N-terminal region
of the protein and a construct mutated in the HSR/CARD
domain (W78R). Only the constructs including the N-termi-
nal portion of the protein are capable to interact with DAXX
protein. This region mapped to aa 1–161 contains both the
HSR/CARD domain and the bipartite nuclear localization
signal motif. Notably the construct carrying the HSR/CARD
domain alone failed to interact with DAXX probably because
the absence of the nuclear localization signal prevents the
proper cellular localization of AIRE needed for the DAXX
interaction. Previous studies carried out by the Ilmarinen et
al. (11) have clearly shown that specific mutations within the
nuclear localization signal prevented the protein from enter-
ing the nucleus. Very interestingly, the protein carrying the
W78R mutation, known to impair AIRE homodimerization
(9), did not interact with DAXX; this fact underlines the
importance of HSR/CARD domain. We thus hypothesize
that the interaction between AIRE and DAXXmight occur as
consequence of the correct dimerization of AIRE. These data
further strengthen the HSR/CARD importance in the AIRE-
DAXX interaction. To establish if the Ser/Pro/Thr-rich
region of DAXX protein is the only domain involved in AIRE
interaction, we produced by site-specific mutagenesis a
pGAD-DAXX construct with a stop codon at position 629.
This construct, which lacks the 111 aa of the C-terminal
moiety, did not produce transformants when cotransformed
with pGBKT7-AIRE (aa 1–517). These results indicated that
the Ser/Pro/Thr-rich region is the only domain involved in
the interaction with AIRE (Fig. 1). We quantified the
strength of interaction by liquid -galactosidase assay.
Unexpectedly, the construct that contains only the DAXX
binding domain interacts three times stronger than the full-
length AIRE protein, probably because of a better exposure
of the domain (Fig. 1).
AIRE and DAXX Interact in Mammalian Cells—To investi-
gate the complex formation in vivo, we expressed in transiently
transfected COS-1 cells pXL5-DAXX and full-length HA-
tagged N- and C-terminal deletions of AIRE. HA-AIRE con-
structs were precipitated from cell lysates with anti-HA anti-
body. Immunoprecipitates (IPs) were analyzed for the presence
of DAXX protein by Western blotting. Only the AIRE con-
structs containing the intact N-terminal portion interacted
with DAXX. Hence, these data indicate that AIRE and DAXX
interact “in vivo” (Fig. 2, A and B). Immunoprecipitated frac-
tions were silver-stained to detect fainter bands corresponding
to the potential AIRE-DAXX complex partners. Attempts to
characterize the additional bands by mass spectrometry tech-
nology failed to identify other partners. The AIRE construct
that contains only the first 100 amino acids did not express in
mammalian cells. Lack of expression could be explained by the
proteasome degradation of ubiquitinylated AIRE as it was
restored in a proteasome inhibition assay (Fig. 3). It is notewor-
thy that the same construct, when expressed in yeast and pro-
karyotic cells as a GAL4 or GST fusion protein, was stabilized
and correctly expressed (data not shown). By transient expres-
sion of V5-AIRE constructs and immunoprecipitation with
anti-V5 from total cell lysates, we found thatAIRE interacts also
with endogenous DAXX. Indeed, DAXX protein was detected
byWestern blots in immunoprecipitated fractions (Fig. 2C). To
further confirm this finding, we performed a colocalization
study in HeLa cells using a fusion GFP-AIRE construct. The
AIRE-DAXX complex was detected by anti-rabbit DAXX pri-
mary antibody and anti-rabbit secondary antibody conjugated
with Texas Red fluorochrome. Confocal microscopy images
showed the colocalization of AIRE and DAXX within the
nucleus (Fig. 4).
AIRE and DAXX Do Not Interact in Vitro—To identify
whether the interaction betweenAIRE andDAXXproteins was
direct or mediated by other proteins, we performed a GST-
pulldown assay. DAXX did not copurify with the GST-AIRE
fusion protein (aa 1–161) that retained the same fraction of
radiolabeled DAXX compared with GST alone (data not
shown). This piece of data indicates that the association
between DAXX and AIRE is weak and is likely to require other
scaffold proteins that increase the stability of the complex.
However, the failed interaction could be due to the lack of the
post-translational modifications such as phosphorylation,
acetylation, or sumoylation that can occur in yeast but not in
bacteria.
DAXX Represses the Transactivation Property of AIRE—Be-
cause DAXX can act as a transcriptional coregulator, the
identification of DAXX interaction with AIRE prompted us
to examine whether DAXX was involved in regulating AIRE
transcriptional activity. To test this hypothesis, we per-
formed transactivation experiments by cotransformation of
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pEF5HA-AIRE with an increasing amount of pXL5-DAXX in
the presence of the pMG3-insulin/Luc promoter reporter
plasmid. These experiments were carried out both in COS-1
and in HeLa cells. Consistent with previous reports, AIRE
induced the expression of the human insulin promoter
reporter activity (28). However the
coexpression of DAXX suppressed
thetranscriptionalactivityinadose-
dependent manner. As shown in
Fig. 5, overexpression of DAXX
reduced by 70% the transactiva-
tion of the insulin promoter in
both HeLa and COS-1 cells.
DAXX Does Not Alter the Forma-
tion of AIRE Homodimers—Ho-
modimer formation is strongly
needed for AIRE to properly trans-
activate. To determine whether the
mechanism by which DAXX re-
presses the transcriptional activity
of AIRE requires the formation of
the AIRE-AIRE complex, we exam-
ined if AIRE homodimers could be
coimmunoprecipitated in COS-1
cells lysates. HA-AIRE and V5-
AIRE were overexpressed in the
presence of increasing amounts of
Xpress-DAXX. No difference was
noticed in the complex formation
even at higher concentrations of
DAXX (Fig. 6). These results sug-
gest that the repression induced by
DAXX was not caused by the dis-
ruption of AIRE homodimers.
DAXX-mediated Repression of
AIRE-dependent Transcription Re-
quires HDACs—To test the hypoth-
esis that HDACs could be involved
in the DAXX-mediated transcrip-
tional repression, we performed
transactivation assays in the presence of TSA, a HDACs inhib-
itor. Cells were cotransfected with AIRE, insulin promoter
reporter gene, and increasing amounts of DAXX in the pres-
ence of TSA. As shown in Fig. 7, down-regulation of insulin
promoter reporter gene was relieved by TSA despite the
increasing amount of DAXX. To confirm HDAC involvement
in AIRE repression, we performed coimmunoprecipitation
experiments in mammalian cells. As shown in Fig. 8 AIRE is
able to interact with endogenousHDAC1 andHDAC2. In sum-
mary, our data suggest that histone deacetylation is involved in
DAXX-mediated repression of AIRE transcriptional activity.
DISCUSSION
Our study aimed to better understand the molecular basis of
self-reactive immune processes and consequently to give a con-
tribution into finding an innovative way to prevent and treat
autoimmune diseases. The purpose of this study was to identify
proteins that interact with AIRE and regulate its activity. The
discovery of new potential AIRE interactors might provide
more insights on the mechanism of action of AIRE and on its
regulation. To test our hypothesis, we performed a yeast two-
hybrid screening using AIRE (aa 1–517) as a bait. Upon screen-
ing of a human thymus library, we identified seven positive
FIGURE 2. Coprecipitation of DAXX with AIRE in COS-1 cells. A, coprecipitation of transfected DAXX with
transfected HA-AIRE and HA-AIRE-(1–161) in COS cells. Cells were transfected with full-length HA-AIRE and
HA-AIRE (aa 1–161). IP was performed from lysates using antibodies against HA (lanes 1 and 2) or beads only
(lane3).Upperpanel shows thecoprecipitatedDAXXof theHA-AIRE IPs.2ndand3rdpanel from the top showthe
relative amount of transfected DAXX and transfected HA-AIRE.WB, Western blot. T.L., total lysate. B, coprecipi-
tationof transfectedDAXXandHA-AIRE constructs inCOScells. Cellswere transfectedwithHA-AIRE andDAXX.
Lanes 1 and 2 of the top panel showDAXX amounts of anti-HA immunoprecipitations performedon cell lysates
transfected with HA-AIRE constructs lacking C-terminal region; lanes 3 and 4 of the same panel show DAXX
amountof anti-HA IPsperformedoncell lysates transfectedwithHA-AIRE constructs lackingN-terminal region.
2nd and 3rd panel from the top show the transfected amount of DAXX and HA-AIRE respectively. C, coprecipi-
tation of endogenous DAXX with transfected V5-AIRE in COS cells. Cells were transfected with V5-AIRE, and IP
was performed from lysates using antibodies against V5 (lane 2) or beads only (lane 1). Upper panel shows the
coprecipitated endogenous DAXX of the V5-AIRE IP. 2nd panel from the top shows the immunoprecipitated
V5-AIR, and lower panels show anti-V5-AIRE expression and endogenous DAXX levels on total lysates.
FIGURE 3.HA-AIRE (aa 1–100) is ubiquitinylated inCOS-1 cells.COS-1 cells
were transfected with HA-AIRE (aa 1–100). After 24 h from transfection cells
were treated with 2 and 5MMG132 (lanes 2 and 3) or left untreated (lane 1).
Upper panel shows anti-HA-AIRE Western blotting (WB). Bottom panel shows
the relative amounts of -actin.
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clones coding for the C-terminal region of the DAXX protein,
corresponding to the Ser/Pro/Thr-rich domain, which is
already known to bindPax3, Pax5, p53, glucocorticoid receptor,
and HDAC2. The AIRE domain involved in this interaction
mapped to the HSR/CARD domain, a key motif responsible for
the homodimerization, nuclear localization, and transactiva-
tion activity of AIRE. This observation was consistent with the
fact that theW78Rmutation localized in this domain abolishes
the interaction between AIRE and DAXX. To confirm the
AIRE-DAXX interaction, we performed colocalization experi-
ments in mammalian cells and carried out coimmunoprecipi-
tation assays by transient transfections of full-length DAXX
and AIRE and their truncation
derivatives. To further validate the
AIRE-DAXX interaction, we per-
formed coimmunoprecipitation
experiments with endogenously
expressed DAXX. Furthermore,
GST-pulldown experiments showed
that the AIRE-DAXX interaction is
weak and requires the presence of
protein mediators assembled in
multiprotein complexes. As re-
sulted in vitro, the failed interaction
could be explained by the lack of
post-translational modifications such as phosphorylation,
acetylation, or sumoylation that can occur in yeast but not in
bacteria. Interestingly, by using transactivation experiments,
we detected that DAXX strongly repressed the transcriptional
activity of AIRE and that histone deacetylation was involved in
DAXX-mediated transcriptional repression. Our experimental
data also showed that DAXX repression did not influence the
formation of AIRE homodimers. The interaction mapped
within the HSR/CARD domain and influenced the transcrip-
tional activity of AIRE. This domain was previously shown by
other authors to mediate the interaction between AIRE and
PIAS1 protein (28), and here we further demonstrated the
significance of the N-terminal HSR/CARD domain in pro-
tein-protein interactions. The new functional characteriza-
tion of the AIRE/CARD domain proposes for AIRE new bio-
logical scenarios and unexpected biochemical pathways.
Indeed, CARD proteins are involved in two major pathways:
regulation of caspase activation both in the context of apo-
ptosis and inflammation and in the regulation of NF-B acti-
vation related to the innate/adaptative immune responses.
Furthermore, the CARD protein family may be divided in
four subfamilies based on their overall domain structures
(50–53) as follows: 1) the NBD-CARDs that contain a nucle-
otide binding domain in addition to the CARD domain; 2)
the coiled-coil CARDs similar to NBD-CARDs with the cen-
tral NBD replaced by a coiled coil motif; 3) the bipartite
CARDs that contain CARD and additional motifs, either a
kinase domain, a DD motif, or a PYD motif; 4) the CARD-
only proteins, which contain a CARD domain but do not
possess any additional recognizable motif.
The AIRE protein may belong to the last category and act
as a positive or negative regulator of the multidomain
CARDs (NBD and coiled coil CARDs) by competing for
binding to their targets. The dimerization process, a very
well known process for AIRE previously described in detail
by our research group and other authors, is also characteris-
tic of CARD-containing proteins. This domain mediates
highly specific protein-protein interactions via homophilic
bridges. This dimerization is also crucial for the proper sub-
cellular localization of the proteins. Given that dimerization
of CARD proteins is critical for their function, it appears
clear how the CARD-mediated interaction between AIRE
and DAXX plays an important role in regulating AIRE activ-
ity. In fact the interaction resulted in a substantial reduction
of AIRE transactivation capability.
FIGURE 4. Colocalization of GFP-AIRE with DAXX. AIRE and DAXX expression constructs were transiently
cotransfected in HeLa cells and then immunostained with Texas Red anti-rabbit secondary antibody. Nuclei
were visualized by 4,6-diamidino-2-phenylindole staining (data not shown).
FIGURE 5. Transactivation properties of AIRE are negatively regulatedby
DAXX. A and B, activation of pMG3-insulin/Luc reporter gene in transfected
HeLa (A) and COS-7 cells (B). HeLa and COS-7 cells were cotransfected with a
pMG3-insulin/Luc firefly luciferase reporter, a control Renilla luciferase
reporter, equal amounts of pEF5HA-AIRE, and increasing amounts of DAXX.
Cells were cultured for 24 h and then lysed, and luciferase activity was meas-
ured on cell lysates. The average in ratio between firefly and Renilla luciferase
activities of lysates was plotted versus AIRE and DAXX expression in same
lysates as assessed by anti-HA and anti-DAXX blots.
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Because both AIRE and DAXX have been described as
negative regulators of NF-B (54, 56),4 it is likely that the
interaction might be required for the inhibition of the
caspase and NF-B pathways. Further investigation will be
necessary to establish their precise effect on these biological
processes. Another level of regulation of the AIRE-DAXX
complex could be in epigenetics. Permissive and repressive
epigenetic changes are finely harmonized to coordinate the
cell type-specific patterns of gene expression that are
responsible for cellular maturation and differentiation. In
agreement with this, it has been observed that the status of
histone methylation can be dynamically regulated by differ-
ent recently discovered histone demethylases, including the
Jumonji (JMJD) and LSD1 family (57–59). To further under-
line the key role of epigenetic regulators, recent biochemical
studies have identified protein complexes having both
H3K27 demethylase and H3K4 methyltransferase activities.
The finding suggests that, at least in some circumstances,
there may be a simultaneous reorganization of both repres-
sive and permissive chromatin states at target promoters
(60). DAXX is a protein already known to bind histones and
recruit histone deacetylases to repress transcription from
target genes. Recent data indicate that AIRE derepresses
controlled genes by inducing epigenetic modifications of the
chromatin, especially in those tissues where normally
restricted genes are ectopically expressed. Recent ChIP on
Chip and expression array studies have shown that AIRE
works on target gene promoters by inducing H3K4me3 and
AcH3 histone modifications typical of active chromatin
states. Moreover, AIRE decreases the levels of H3K27me3,
an epigenetic marker of transcriptional repression (24).
Based on these data, we propose a model to explain the reg-
ulatory consequences of the interaction between AIRE and
DAXX (Fig. 9). In the first step, AIRE binds histone H3 in its
unmethylated K4me0 form, where it recruits a specific H3K4
methyltransferase that, by modifying Lys-4 from the
unmethylated to the trimethylated form H3K4me3, leads to
an active chromatin state. Histone methylation is a dynamic
and reversible process that needs to be promptly counterbal-
anced in accordance with changes in the phase of the cell
cycle. It is also widely accepted that the chromatin repres-
sion mechanisms are implemented by the simultaneous
occurrence of deacetylation and demethylation. This task
requires tight cooperation between histone demethylases
and HDACs as highlighted by the RBP2-HDAC complex
(30). We suppose that the DAXX-HDAC complex is part of a
larger demethylase complex that might mediate AIRE
repression through both histone deacetylation and H3K4
demethylation. Very interestingly, a recent work has shown
that DAXX colocalizes with the lysine-specific demethylase
(LSD)-HDAC1,2-COREST-REST complex further support-
ing the role of DAXX in complexes with dual demethylase/
4 Y. Tao, W. Wheat, C. Williams-Skipp, D. Gutches, D. Wegmann, and R. Schei-
nman, unpublished data.
FIGURE 6. Homodimerization inhibition assay. DAXX has no influence on
AIRE homodimer formation. COS-1 cells were transfected with V5-AIRE, HA-
AIRE, Xpress-DAXX, and IPs were performed from lysates using antibodies
against V5 (lanes 2–5) or beads only (lane 1). Upper panel shows anti AIRE-HA
blot (homodimer formation). 2nd panel from top shows V5-AIRE. 3rd panel
shows endogenous and transfected DAXX levels (lanes 1–5). Lower panels
show anti-HA and -actin blots on total lysates (T.L.).WB,Western blot.
FIGURE 7. Presence of TSA abolishes the negative influence operated by
DAXX protein on the transactivation properties of AIRE. Activation of
pMG3-insulin/Luc reporter in transfectedHeLa.HeLa cellswere cotransfected
with a pMG3-insulin/Luc firefly luciferase reporter, a control Renilla luciferase
reporter, equal amounts of pEF5HA-AIRE, and an increasing amounts of
DAXX. Cellswere left untreated for 5 h after transfection and then cultured for
24 h in presence of TSA (100 ng/ml). Cells were then lysed, and luciferase
activitywasmeasured on cell lysates. The average in ratio between firefly and
Renilla luciferase activities of lysates was plotted versus AIRE and DAXX
expression in same lysates as assessed by anti-HA and anti-DAXX blots.
FIGURE 8.Coprecipitation of endogenousHDAC1 andHDAC2with trans-
fected HA-AIRE in COS cells. COS-1 cells were transfected with full-length
HA-AIRE. IPs were performed from lysates using antibodies against HDAC1
andHDAC2.Upper panel shows the coprecipitatedHA-AIRE of anti-HDAC1 IP;
bottom panel shows the coprecipitated HA-AIRE of anti-HDAC2 IP. LT, total
lysate.
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deacetylase activity (49). Moreover, Lys-4 demethylation is
linked to the H3K27 trimethylation, which associates with
inactive chromatin states (55). The inactivity of the H3K27
histone methyltransferase complex and the consequent
recovery of the active chromatin state might occur through
the interaction between AIRE and one or more proteins of
the H3K27 complex as supported by our unpublished data,5
which prove the physical interaction of AIRE with a member
of the polycomb protein belonging to the H3K27 histone
methyltransferase complex. We have mapped the interac-
tion within the repression domain of the polycomb protein
that is expected to hinder the repressive capability of the
complex. This point represents a topic of considerable inter-
est, and it needs to be studied in depth. In conclusion, we
report here the identification of a novel interacting partner
for AIRE. Our data further extend the knowledge of the
molecular pathways involved in the establishment andmain-
tenance of the immunological tolerance and might give a
contribution to the development of therapeutic strategies to
prevent and treat autoimmune diseases.
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